hmpl-760
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 4, 2022 (NCT05190068)
Timeline
Indications
Studied for
Mechanism of action
- Tyrosine-protein kinase BTKANTAGONIST
BTK antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06601504 | Phase 2 | Nov 5, 2024 | Jiao Tong University, University of Washington |
| NCT05176691 | Phase 1 | Feb 15, 2022 | Hutchison MediPharma, University of Washington |
| NCT05190068 | Phase 1 | Jan 4, 2022 | Hutchison MediPharma, Jiao Tong University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hutchison MediPharma | For profit | 2 | 1 | 1 | 2022 |
| Jiao Tong University | Academic/Hospital | 2 | 0 | 2 | 2022 |
| University of Washington | Academic/Hospital | 2 | 2 | 2 | 2022 |
3 organizations
Page 1 / 1